Goldman Sachs' Salveen Richter believes we've only scratched the surface of Moderna's potential. Investors seek MRNA stock predictions and analysis amid promising biotech advancements. Stay updated with Moderna news, exploring its flagship CEO's vision for the future of biotechnology. Gain insights into MRNA stock's performance today.